Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Sher

Showing results (141-150 of 159) with videos related to

Pageof 16
Sort By:
Oral Oncology|April 25, 2020
Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risksAndrew T Day, David J Sher, Rebecca C Lee, et al.
JAMA Otolaryngology-- Head & Neck Surgery|June 29, 2023
Long-term Patient-Reported Outcomes in a Population-Based Cohort Following Radiotherapy vs Surgery for Oropharyngeal CancerMichael J Dohopolski, Kevin Diao, Katherine A Hutcheson, et al.
Cancer|September 9, 2021
Substance use and mental health burden in head and neck and other cancer survivors: A National Health Interview Survey analysisSanjana Balachandra, Rebecca L Eary, Rebecca Lee, et al.
Practical Radiation Oncology|December 12, 2022
Preliminary Evaluation of PTV Margins for Online Adaptive Radiation Therapy of the Prostatic FossaHoward E Morgan, Kai Wang, Yulong Yan, et al.
International Journal of Radiation Oncology, Biology, Physics|January 16, 2023
PREVLAR: Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck ChemoradiotherapyMarcelo Bonomi, Dukagjin M Blakaj, Rafi Kabarriti, et al.
Oral Oncology|October 1, 2016
Patterns of failure after reirradiation with intensity-modulated radiation therapy and the competing risk of out-of-field recurrencesDanielle N Margalit, Bhupendra Rawal, Paul J Catalano, et al.
Head & Neck|January 9, 2019
IMRT-based treatment of unknown primary malignancy of the head and neck: Outcomes and improved toxicity with decreased mucosal dose and larynx sparingAnna W LaVigne, Danielle N Margalit, Bhupendra Rawal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2018
Post-Treatment Mortality After Surgery and Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung CancerWilliam A Stokes, Michael R Bronsert, Robert A Meguid, et al.
Plos One|April 15, 2014
Low incidence of chest wall pain with a risk-adapted lung stereotactic body radiation therapy approach using three or five fractions based on chest wall dosimetryThibaud P Coroller, Raymond H Mak, John H Lewis, et al.
Head & Neck|February 14, 2019
Unique mutation patterns in anaplastic thyroid cancer identified by comprehensive genomic profilingSaad A Khan, Bo Ci, Yang Xie, et al.
Pageof 16

Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
Oral Oncology|April 25, 2020
Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risksAndrew T Day, David J Sher, Rebecca C Lee, et al.
JAMA Otolaryngology-- Head & Neck Surgery|June 29, 2023
Long-term Patient-Reported Outcomes in a Population-Based Cohort Following Radiotherapy vs Surgery for Oropharyngeal CancerMichael J Dohopolski, Kevin Diao, Katherine A Hutcheson, et al.
Cancer|September 9, 2021
Substance use and mental health burden in head and neck and other cancer survivors: A National Health Interview Survey analysisSanjana Balachandra, Rebecca L Eary, Rebecca Lee, et al.
Practical Radiation Oncology|December 12, 2022
Preliminary Evaluation of PTV Margins for Online Adaptive Radiation Therapy of the Prostatic FossaHoward E Morgan, Kai Wang, Yulong Yan, et al.
International Journal of Radiation Oncology, Biology, Physics|January 16, 2023
PREVLAR: Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck ChemoradiotherapyMarcelo Bonomi, Dukagjin M Blakaj, Rafi Kabarriti, et al.
Oral Oncology|October 1, 2016
Patterns of failure after reirradiation with intensity-modulated radiation therapy and the competing risk of out-of-field recurrencesDanielle N Margalit, Bhupendra Rawal, Paul J Catalano, et al.
Head & Neck|January 9, 2019
IMRT-based treatment of unknown primary malignancy of the head and neck: Outcomes and improved toxicity with decreased mucosal dose and larynx sparingAnna W LaVigne, Danielle N Margalit, Bhupendra Rawal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2018
Post-Treatment Mortality After Surgery and Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung CancerWilliam A Stokes, Michael R Bronsert, Robert A Meguid, et al.
Plos One|April 15, 2014
Low incidence of chest wall pain with a risk-adapted lung stereotactic body radiation therapy approach using three or five fractions based on chest wall dosimetryThibaud P Coroller, Raymond H Mak, John H Lewis, et al.
Head & Neck|February 14, 2019
Unique mutation patterns in anaplastic thyroid cancer identified by comprehensive genomic profilingSaad A Khan, Bo Ci, Yang Xie, et al.
Pageof 16